What Aperture Venture Partners does

Aperture Venture Partners is a New York-based, healthcare-focused venture capital firm established in 2002. The firm invests in early-stage and growth-stage companies across medical device, pharmaceutical, healthcare IT/services, and diagnostic sectors, partnering with entrepreneurs to build and scale innovative healthcare businesses. The firm operates with a small team of four partners and deploys capital into portfolio companies while providing strategic, operational, M&A advisory, and corporate governance support. Aperture's core competency is healthcare domain expertise, with two partners holding MD degrees, and additional backgrounds spanning investment banking (UBS), consulting (Parthenon Group), and prior venture capital (Prism Ventures, MDS Capital). Partner Thomas P. Cooper, M.D. previously founded three healthcare companies — Spectrum Emergency Care, Correctional Medical Services, and Mobilex USA — that collectively generated over $2 billion in revenues, served more than four million patients across all 50 states, and were acquired by Laidlaw and Integrated Health Services. Partner Paul E. Tierney, Jr. co-founded Gollust, Tierney and Oliver, the general partner for Coniston Partners, a $1 billion active value investment partnership. The firm's business model follows a traditional VC structure: it raises capital from limited partners, deploys it into portfolio companies, and generates returns through successful exits. Its exit track record includes 10+ portfolio companies that achieved valuations exceeding $1 billion, including Inspire Medical, Axonics, Biohaven Pharmaceuticals, Tarsus Pharmaceuticals, Mako Surgical, Cameron Health, Conor Medsystems, Trevi Therapeutics, Collegium Pharmaceutical, and Aclaris Therapeutics. The firm currently maintains active investments in seven companies — Cortica, Cardiac Dimensions, Miach Orthopaedics, Neuros Medical, Shiratronics, Ulab, and XII Medical — and recently co-invested with EQT Life Sciences in Neuros Medical's $56 million Series D funding round.

Name

Aperture Venture Partners

Legal name

APERTURE Venture Partners, LLC

Website

https://aperturevp.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

1–10 employees

Short description

Aperture Venture Partners is a New York-based, healthcare-focused venture capital firm founded in 2002 that invests in early-stage and growth-stage medical device, pharmaceutical, healthcare IT/services, and diagnostic companies, supported by a four-partner team with deep clinical and investment expertise and a track record of 10+ portfolio exits exceeding $1 billion in valuation.

Ownership category

akta.pro rank

Product category

Venture Capital (Healthcare)

NAICS

All Other Financial Investment Activities (52399)

SIC

Investment Advice (6282)

akta.pro primary industry

Sector-Focused Venture Capital (Vertical Specialists) (FSANAAAD)

Keywords

• Healthcare venture capital
• Medical device investment
• Life sciences funding
• Pharmaceutical venture investing
• Diagnostic startup capital

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Core offering

Aperture Venture Partners is a healthcare-focused venture capital firm that invests capital in early-stage and growth-stage companies in the medical device, pharmaceutical, healthcare IT/services, and diagnostic sectors, partnering with entrepreneurs and providing strategic guidance, board oversight, M&A advisory, and operational support to help portfolio companies achieve successful exits. The firm does not sell commercial products or software; its offering is the investment partnership and the strategic/operating expertise contributed by its partners across the portfolio.

Product overview

Aperture Venture Partners is a healthcare-focused venture capital investment firm. Rather than offering a product platform, the firm provides investment capital, strategic guidance, and operational expertise to early-stage and growth-stage companies in the medical device, pharmaceutical, healthcare IT/services, and diagnostic sectors. The firm's investment approach centers on partnering with exceptional entrepreneurs to build innovative companies, with its partners offering deep industry knowledge and operational support to help portfolio companies realize their potential and achieve successful exits.

Differentiator

Problem solved

Functional benefit

Products and services

• Healthcare Venture Capital Investment Equity capital investment in early- and growth-stage companies in medical device, pharmaceutical, healthcare IT/services, and diagnostic sectors, paired with partner-led board oversight, strategy, M&A advisory, and operational support, for founders and management teams of privately held healthcare companies.

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves3 records

Expansion highlights3 records

Direct peers

• SV Health Investors: Healthcare-focused venture and growth firm with deep expertise in biotech, medtech, and healthtech — closely aligned subsector mix and stage profile to Aperture.
• OrbiMed Advisors: One of the largest healthcare-focused investment firms globally, investing across medical devices, pharmaceuticals, diagnostics, and digital health — directly comparable to Aperture's vertical focus but at significantly larger AUM.
• Frazier Healthcare Partners: Healthcare-dedicated venture and growth firm focused on life sciences, medical devices, and healthcare services — a direct peer given overlapping subsectors and stage orientation.
• Versant Ventures: Healthcare-focused venture firm investing in biopharma, medical devices, and healthcare services with a similar subsector mix to Aperture and comparable stage profile.
• 5AM Ventures: Early-stage venture firm focused exclusively on life sciences (biopharma and medical devices) — closely comparable in vertical specialization and stage orientation to Aperture.
• Domain Associates: Healthcare-focused venture firm with deep experience in medical devices, pharmaceuticals, and diagnostics — a direct competitor for healthcare VC deal flow.
• ARCH Venture Partners: One of the pioneering healthcare/biotech-focused venture firms investing across devices, diagnostics, and therapeutics — comparable vertical mandate and longevity.

Regional players

• EQT Life Sciences: European-headquartered healthcare investor (formerly LSP) that has co-invested alongside Aperture (e.g., Neuros Medical $56M Series D) — directly comparable in healthcare focus with a transatlantic reach.

Broad incumbents

• New Enterprise Associates (Healthcare): Large multi-stage firm with a substantial dedicated healthcare practice covering devices, biopharma, and healthtech — overlaps with Aperture's thesis but operates at far greater scale.
• Deerfield Management: Healthcare-focused investment manager across venture, public equities, and structured finance — competes with Aperture in early-stage healthcare while offering broader capital solutions.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments65 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aperture Venture Partners